Çocukluk çağı lenfomaları ve kemik etkilenmesi

Çocukluk çağı lenfomalarında (Hodgkin dışı lenfoma ve Hodgkin hastalığında) hastalığın kendisi veya uygulanan kemoterapötikler nedeniyle kemik metabolizmasında de- ğişiklikler görülebilir. Bu makalede çocukluk çağında sık görülen bu iki tümöral hastalığın kemikler üzerine etkileri derlenmiştir.

Childhood lymphoma and bone interaction

In pediatric lymphomas (Non-Hodgkin’s lymphoma and Hodgkin’s disease), changing in bone metabolism can be seen, both because of the disease itself or applied che- motherapeutics. In this article, bone affections in two fre- quently seen pediatric tumoral diseases are discussed.

PDF

___

1. Büyükpamukçu M. Hodgkin Dışı Lenfomalar. Klinik Gelişim 2007;2:44-48.
2. Sevinir B, Büyükpamukçu M. Çocukluk çağı lenfomaları. Katkı Pediatri Dergisi 1995;4:476.
3. Rosenthal H, Kolb R, Gratz KF, Reiter A, Galanski M. Bone manifestations in non-Hodgkins lymphoma in childhood and adolescence. Radiologe 2000;40:737-744.
4. Gürmen N. Çocukluk çağında görülen primer ve sekonder malign kemik tümörlerinde radyolojik bulgular. Katkı 1985;6:63-71.
5. Hesseling PB, Hough SF, Nel ED, Van Riet FA, Beneke T, Wessels G. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl.1998;11:44-47.
6. Lanzkowsky P. Hodgkin Disease. In: Lanzkowsky P ed. Manual of Pediatric Hematology and Oncology. 4th edn. San Diego: Elsevier Academic Pres, 2005;453-90.
7. Arikoski P, Komulainen J. Development of bone mineral density in children with cancer. Pediatric Endocrinology. LWPES/ESPE. 6th. Joint meeting. Montreal. 6-10, 2001;3- 172.
8. Nysom K, Holm K, Michaelsen K, Hertz H, Müller J, Molgaard C. Bone mass after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 2001; 37: 518-524.
9. Brigham BA, Bunn PA, Horton JE et al. Skeletal manifestations in cutaneous T–cell lymphomas. Arch Dermatol 1982;118:461-467.
10. Sala A, Talsma D, Webber C, Posgate S, Atkinson S, Barr R. Bone mıneral status after treatment of malignant lymphoma in childhood and adolescence. Eur J Cancer Care 2007;16:373-379.
11. Köseoğlu V, Büyükpamukçu M, Bayhan H. Lenfoma tanısıyla tedavi edilmiş çocuklarda kemik mineral dansitesi ve serum osteokalsin, carboxyterminal propeptid type I pro- collagen ve ICTP düzeyleri. X. Pediatrik Onkoloji Kongre- si. 22-24 Ekim 1998.Ankara S:91.
12. Redman JR, Bajorunas DR,Wong G et al. Bone mineralization in women following succesful treatment of Hodgkin’s disease. Am J Med 1988; 85:65-72.
13. Bluemke DA, Zerhouni EA. MRI of avascular necrosis of bone. Top Magn Reson Imaging 1996;8:231-246.
14. Frisch B, Bartl R. Osteoporosis. In: Frisch B, Bartl R,eds. Biopsy interpretation of bone and bone marrow. London, 1999:62-69.
15. Morakkabati N, Strunk H, Gutjahr P. MRI diagnosis and follow-up of bilateral necrosis of the humeral head as a complication after chemotherapy. Aktuelle Radiol 1997;7:41-44.
16. Brooks PM. Rheumatic manifestations of neoplasia. Curr Opin Rheumatol 1992;4:90-93.
17. Georgescu L, Quinn GC, Schwartzman S, Paget SA. Lymphoma in patients with rheumatoid arthritis. Semin Arthritis Rheum 1997;26:794-804.
18. Seda H, Alarcon GS. Musculoskeletal syndromes associated with malignancies. Curr Opin Rheumatol 1995;7:48-53.
19. Kohout A, Resl M, Bácová M. Pulmonary changes in rheumatoid arthritis. Cesk Patol 2001;37:105-7.
20. Falcini F, Bardare M, Cimaz R, Lippi A, Corona F. Arthritis as a presenting feature of non-Hodgkin’s lymphoma. Arch Dis Child 1998;78:367-370.
21. Trapani S, Grisolia F, Simonini G, Calabri GB, Falcini F. Incıdence of occult cancer in children presenting with musculoskeletal symptoms. a 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheum 2000;9:348-359.
22. Wilson S, Brooks PM. Rheumatic manifestations of neoplasia. Curr Opin Rheumatol 1993;5:99-103.
23. Gaudin P, Juvin R. Rozand Y, et al: Skeletal involvement as the initial disease manifestation in Hodgkin’s disease: a review of 6 cases. J Rheumatol 1992;19:146-152.
24. Felix R, Hofsetter W, Cecchini MG. Recent developments in the understanding of the pathophsiology of osteopetrosis. Eur J Endocrinol 1996;134:143-156.
25. Hashino S, Hirota G, Hasegawa M, et al. Peripheral T-cell lymphoma in a patient with osteopetrosis. Ann Hematol. 2001;80:376-378.
26. Shibuya H, Suzuki T, Matsubara S, Suzuki S. Non-Hodgkins lymphoma in a patient with osteopetrosis. Lymhology. 1986;19:90-92.
27. Doğru D, Çamur S, Öztürk R . Pediatrik onkolojik aciller. Katkı 1995;4:639-642.
28. Syed MA, Horwitz MJ, Tedesco MB, Garcia A,Wisniewski SR, Stewart AF. Parathyrold hormone related protein stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. J.Clin Endocrinol Metab. 2001;86:1525-1531.
29. Vergin C, Atlıhan F. Kemiğin non-hodgkin lenfoması. İzmir Devlet Hast Tıp Derg 1993;3:41-50.
30. Kremer R, Shustik C, Tabak T, Papavasiliou V, Goltzman D. Parathyroid hormone related peptide in hematologic malignancies. Am J Med 1996;100:406-411.
31. Motellon JL, Jimenez FJ, de Miguel F. Relationship of plasma bone cytokines with hypercalcemia in cancer patients. Clin Chim Acta 2000;302:59-68.
32. Sezer MT, Duranay M . Hiperkalsemi. Klinik Serileri 1992;3:27-29.
33. Haspolat K. Hiperkalsemi. II. Ulusal Pediatrik Endokrinoloji Kongresi, İzmir, 1997. s:111- 9.
34. Quinn JM, Athanasou NA. Tumour infltrating macrophages are capable of bone resorption. J Cell Sci 1992;101:681-686.
35. Mundy GR. Hypercalcemia in hematologic malignancies and in solid tumors associated with extensive localized bone destruction. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 2nd edn. Philadelphia. Lippincott-Raven, 1999: p.173.